Barrier and Transporter Days 2026

We invite you to participate in the 25th Barrier and Transporter Days taking place in Bad Herrenalb/Black Forest close to Karlsruhe, Germany, from June 1st to June 3rd, 2026. 

Subjects of this conference are membrane transport proteins in barrier organs, drug transport and drug delivery across biological membranes, screening models such as MCDK, Caco-2 cells, blood brain barrier cells, skin cells, hepatocytes and others as well as colloidal carriers (nanoparticles, liposomes) in drug delivery. Please forward this message also to colleagues in your department. This conference might also be of special interest for PhD students to get in contact with participating colleagues from the pharma industry.  

Please register and submit an abstract for poster or oral presentation until Friday, May 15th 2026.  Registration fee is 350,- € covering 2 nights with complete room and board (breakfast, lunch, dinner). In case of questions please call +49-6221-548336 or send an email to transportertage@googlemail.com

Herrenalber Transportertage 

We thank our sponsors : 

Confirmed talks 2025

•       Integrating Predicted Efflux into the Screening Process

•       Interaction of man-made compounds with ABC drug transporters determined with cell-based and with protein-based assays

•       New model describing the proton gradient driven activity of MATEs transporters

•       Microthrombi as Size-Selective Gateways for Nanoparticle Delivery to the Brain

•       Inhibition of Clostridium botulinum C2 toxin by fibrinogen

•       Binding Kinetics of Bacterial Periplasmic Substrate-Binding Proteins and Their Role in Nutrient Acquisition

•       Vascular transferrin receptor expression and function in the young and aged brain

•       Energy-driven permeability threshold for active transport

•       Blood brain barrier: a bridge between nutrition and brain lipid homeostasis 

•       Multifunctional peptide nanocarrier for targeted reduction of metastatic breast carinoma-induced osteolysis

•       Cystic Fibrosis: why sodium hyperabsorption is a wrong concept 

•       The role of the blood-brain barrier in neurodegenerative diseases

•       Cell penetrating peptide modified liposomes: A technology for oral peptide delivery

•       New insights into the role of ABC transporters in amyloid beta clearance

•       New strategies against ABC transporter-mediated anticancer drug resistance

  to be continued